ARTICLE | Company News
Ferring sales and marketing update
July 18, 2016 7:00 AM UTC
The U.K.’s NICE issued final draft guidance recommending the use of Firmagon degarelix from Ferring to treat advanced hormone-dependent prostate cancer in patients with spinal metastases. The recomme...